Previous close | 8.30 |
Open | 8.30 |
Bid | 10.90 |
Ask | 16.80 |
Strike | 460.00 |
Expiry date | 2024-10-18 |
Day's range | 8.30 - 8.30 |
Contract range | N/A |
Volume | |
Open interest | 35 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.